David
Jiménez Castro
Profesor/a Titular Universidad
McMaster University
Hamilton, CanadáPublications en collaboration avec des chercheurs de McMaster University (19)
2024
-
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review
Journal of the American College of Cardiology, Vol. 83, Núm. 3, pp. 444-465
2023
-
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
Thrombosis Research, Vol. 222, pp. 31-39
-
Sex-Related Differences in Patient Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study
Seminars in Thrombosis and Hemostasis, Vol. 49, Núm. 7, pp. 725-735
2022
-
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347
-
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review
JAMA Cardiology, Vol. 7, Núm. 7, pp. 747-759
-
Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial
Thrombosis and Haemostasis, Vol. 122, Núm. 5, pp. 857-866
-
Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study
Thrombosis Research, Vol. 214, pp. 122-131
-
Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment
Contemporary Clinical Trials, Vol. 115
2021
-
Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database
The Lancet Respiratory Medicine, Vol. 9, Núm. 1, pp. 33-42
-
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
Journal of the American College of Cardiology, Vol. 77, Núm. 15, pp. 1903-1921
2020
-
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Journal of the American College of Cardiology, Vol. 75, Núm. 23, pp. 2950-2973
-
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE
Journal of Thrombosis and Thrombolysis, Vol. 50, Núm. 2, pp. 267-277
-
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Thrombosis and Haemostasis, Vol. 120, Núm. 7, pp. 1004-1024
2019
-
Hemopericardium and Cardiac Tamponade as a Complication of Vena Caval Filters: Systematic Review of the Published Literature and the MAUDE Database
Clinical and Applied Thrombosis/Hemostasis
-
Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry
Seminars in Thrombosis and Hemostasis, Vol. 45, Núm. 8, pp. 793-801
2018
-
Systematic review of efficacy and safety of retrievable inferior vena caval filters
Thrombosis Research
-
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism
American Journal of Medicine, Vol. 131, Núm. 4, pp. 430-437
2017
-
Rivaroxaban with or without aspirin in stable cardiovascular disease
New England Journal of Medicine, Vol. 377, Núm. 14, pp. 1319-1330
2016
-
Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report
Chest, Vol. 149, Núm. 2, pp. 315-352